CN1307876A - Xinmaikang medicine - Google Patents

Xinmaikang medicine Download PDF

Info

Publication number
CN1307876A
CN1307876A CN00113515A CN00113515A CN1307876A CN 1307876 A CN1307876 A CN 1307876A CN 00113515 A CN00113515 A CN 00113515A CN 00113515 A CN00113515 A CN 00113515A CN 1307876 A CN1307876 A CN 1307876A
Authority
CN
China
Prior art keywords
parts
radix
medicine
rhizoma
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN00113515A
Other languages
Chinese (zh)
Other versions
CN1135107C (en
Inventor
任开益
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001135155A priority Critical patent/CN1135107C/en
Publication of CN1307876A publication Critical patent/CN1307876A/en
Application granted granted Critical
Publication of CN1135107C publication Critical patent/CN1135107C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a Chinese medicine Xinmaikang-soluble granules preparation made of 14 Chinese medicinal materials of gastrodia, salvia root, carthamus flower, chrysanthemum flower, ledebouriella root, astragalus root, ligusticum and so on through the processes of heating, decocting, concentrating, evaporative dewatering, and roasting and drying. It has no toxic side effect, and can obtain obvious therapeutic effect for curing the diseases of hypertension, hyperlipemia, high blood viscosity, cerebral arteriosclerosis, coronary heart disease, fatty lever and vertebrobasilar ischemia, etc. and can obtain the good of preventing apoplexy.

Description

Xinmaikang medicine
The present invention relates to a kind of cardiovascular diseases's of being used for Chinese medicine, particularly a kind of Chinese patent medicine that can be used for treating cardiovascular diseases and prevention of stroke.
At present, the document and the medicine of domestic existing treatment coronary heart disease and experimental atherosclerosis, " Xinmaikang medicine treatment coronary heart disease 30 examples " that the bright grade of Qin's nasal mucus is write have been published as " the Shaanxi traditional Chinese medical science " 1997.18 (3): 111, introduced by Chinese drug-treated group such as the Radix Astragali, Radix Ginseng, Radix Ophiopogonis, Ramulus Cinnamomi, Radix Puerariae, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, GUANG Radix Notoginseng, Fructus Crataegi, the Radix Polygoni Multiflori, Radix Glycyrrhizaes and become Xinmaikang medicine, treatment coronary heart disease has been had certain curative effect; " Chinese medicine research " 1996-(2) 48-49 has published " Xinmaikang medicine is to the preventive effect of Carnis Coturnicis japonicae experimental atherosclerosis " that Wu Jibiao etc. writes, introduced a kind of Xinmaikang medicine of forming by Radix Polygoni Multiflori, Rhizoma Polygonati, Pollen Tyjphae, Rhizoma Alismatis, Rhizoma Chuanxiong etc., experimental atherosclerosis has been had certain preventive effect; The Chinese Traditional Medicines of selling on the market have network glad logical etc., and its therapeutic effect has certain limitation.
In the disclosed prescriptions of Chinese medicine of Chinese medicine neutralization, be usually used in treating hypertension, the common drug of the suppressing the hyperactive liver to relieve the wind syndrome method of disease such as cerebral arteriosclerosis and hyperlipemia has: Rhizoma Gastrodiae, Ramulus Uncariae Cum Uncis, Concha Haliotidis, Semen Cassiae, Herba Taxilli, Haematitum, Radix Scutellariae, Radix Gentianae, Flos Chrysanthemi, the Cortex Eucommiae, Spica Prunellae, the Radix Paeoniae Alba, Herba Leonuri, Radix Achyranthis Bidentatae etc., the common drug that is used for the resolving phlegm lowering turbidity method has: the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Poria, Fructus Aurantii Immaturus, Caulis Bambusae In Taenia, Rhizoma Gastrodiae, the Rhizoma Atractylodis Macrocephalae, Bulbus Fritillariae Thunbergii, Rhizoma Acori Graminei, Radix Curcumae, Haematitum, Concretio Silicea Bambusae, Arisaema Cum Bile etc., the common drug that is used for the expectorant stasis of blood and method of treatment has: the Rhizoma Pinelliae, Fructus Trichosanthis, Bulbus Fritillariae Thunbergii, Arisaema Cum Bile, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Rhizoma Gastrodiae, Semen Persicae, Flos Carthami, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Rhizoma Acori Graminei, Radix Curcumae etc., the common drug that is used for the activating qi and collateral method has: the Radix Astragali, Radix Angelicae Sinensis, Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Puerariae, Ramulus Cinnamomi etc., the common drug that is used for the nourishing the liver and kidney method has: the Radix Astragali, Radix Angelicae Sinensis, Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Pheretima, Radix Salviae Miltiorrhizae, Radix Puerariae etc.
But the object of the present invention is to provide a kind of Chinese patent medicine Xinmaikang medicine that can be used for treating diseases such as hypertension, hyperlipidemia, high blood viscosity, cerebral arteriosclerosis, coronary heart disease, fatty liver and vertebral-basilar artery insufficiency and prevention of stroke.
The object of the present invention is achieved like this.With Rhizoma Gastrodiae, Flos Chrysanthemi, Concha Haliotidis, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, Radix Achyranthis Bidentatae, Rhizoma Alismatis is monarch drug, be used for suppressing the hyperactive liver and subsiding YANG, enriching yin and nourishing kidney, with Radix Salviae Miltiorrhizae, Flos Carthami, Radix Saposhnikoviae, Radix Astragali, Rhizoma Chuanxiong, Fructus Crataegi, the Cortex Eucommiae, Radix Puerariae, Scorpio, Semen Raphani is ministerial drug, being used to be turbid eliminates the phlegm, benefiting QI for activating blood circulation, invigorating the spleen and regulating the stomach, at first by the processing concocted specification crude drug in whole each component is carried out preliminary working respectively; Crude drug in whole that processing is cooked and decoction pieces drop into multi-function extractor then, the water that adds 4-8 times of drug weight, heat and decoct, 40 minutes to the 2 hours after-filtration that simmer in water after the boiling for the first time, the water that adds 2-6 times of drug weight for the second time boils after slow fire boils 30-60 minute after-filtration; Again twice filtering liquid medicine being dropped into vacuum concentrator concentrates, after concentrating, take out to drop in the jacketed pan and carry out water evaporates, put into the thermal cycle drying baker again, temperature in the drying baker is controlled between 50-65 ℃, take out after dry about 5-9 hour, absolutely dry glue sheet medicine, through purifying, add excipient and form dissolved granule again.The ratio of crude drug in whole each component (weight ratio) is: Rhizoma Gastrodiae 15-25 part, Radix Salviae Miltiorrhizae 25-35 part, Flos Carthami 1-6 part, Flos Chrysanthemi 5-15 part, Radix Saposhnikoviae 5-15 part, Radix Astragali 40-60 part, Rhizoma Chuanxiong 1-10 part, Fructus Crataegi 10-25 part, Cortex Eucommiae 5-15 part, Radix Puerariae 25-35 part, Scorpio 5-15 part, Concha Haliotidis 25-35, Rhizoma Alismatis 5-15 part, Semen Raphani 15-25.The optimum formula ratio (weight ratio) of crude drug in whole each component is: 20 parts in Rhizoma Gastrodiae, 30 parts of Radix Salviae Miltiorrhizaes, 3 parts on Flos Carthami, 10 parts of Flos Chrysanthemis, 10 parts of Radix Saposhnikoviaes, 50 parts of Radix Astragali, 6 parts of Rhizoma Chuanxiongs, 15 parts of Fructus Crataegis, 10 parts of the Cortexs Eucommiae, 30 parts of Radix Puerariaes, 10 parts of Scorpio, 30 parts of Concha Haliotidis, 10 parts of Rhizoma Alismatis, 20 parts of Semen Raphanis.
Advantage of the present invention is: the present invention is by decocting natural Chinese medicines in proportion, concentrate, making Chinese patent medicine after the operation such as evaporation, baking, it has no side effect, diseases such as apoplexy high risk patient such as hypertension, hyperlipidemia, high blood viscosity, cerebral arteriosclerosis, coronary heart disease, fatty liver and vertebral-basilar artery insufficiency there is fairly obvious curative effect, can reaches the purpose of prevention of stroke simultaneously.
Modern medicine is thought: high-risk apoplexy diseases such as hypertension, hyperlipidemia, high blood viscosity, cerebral arteriosclerosis, coronary heart disease, rheumatic heart disease, fatty liver, obesity and vertebral-basilar artery insufficiency are to cause systemic circulation anoxia and the anoxybiotic principal element of local circulation.Because brain is very responsive to anoxia, the anoxia that circulates for a long time causes symptoms such as internal respiration depletion and cerebral anoxia particularly outstanding.The present invention is by the speckle of blood pressure lowering, blood fat reducing, viscosity reduction, removing blood vessel scleratheroma, softening hardened blood vessel, blood flow increasing, improve the quality of taking oxygen of blood, improve the circulation anoxia, the depletion of correction internal respiration, thus improve the apoplexy high-risk group's be in half health status quality of life and increase work efficiency, myocardial infarction also there is the excellent prevention effect.
The present invention is except that having adopted Chinese medicine to treat in cardiovascular prescription each component commonly used and utilize its basic pharmacology, components such as the Radix Saposhnikoviae that is of little use in traditional Chinese medicine cardiovascular diseases's the prescription, Radix Puerariae, Semen Raphani have also been adopted, wherein mainly be to adopt the diffusing wind of Radix Saposhnikoviae and stimulate the menstrual flow to reach network, use together with the product that reduce phlegm with blood, and play that phlegm-fire is clear, QI and blood and effect, the property that the utilization Radix Saposhnikoviae leads to walk among the we, his medicine relieving the exterior syndrome of band we is walked network; Adopting Semen Raphani is because it has the effect of lowering the adverse-rising QI and dispelling phlegm; Adopt Radix Puerariae to be because its abnormal smells from the patient is all thin, can rise the gas of sending out the clear sun of taste, can make not reason insufficiency of vital energy and blood and withering of extremity.
Embodiment 1: with Rhizoma Gastrodiae, Flos Chrysanthemi, Concha Haliotidis, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, Radix Achyranthis Bidentatae, Rhizoma Alismatis is monarch drug, be used for suppressing the hyperactive liver and subsiding YANG, enriching yin and nourishing kidney, with Radix Salviae Miltiorrhizae, Flos Carthami, Radix Saposhnikoviae, Radix Astragali, Rhizoma Chuanxiong, Fructus Crataegi, the Cortex Eucommiae, Radix Puerariae, Scorpio, Semen Raphani is ministerial drug, being used to be turbid eliminates the phlegm, benefiting QI and nourishing blood, invigorating the spleen and regulating the stomach, amount to YIN and YANG in a relative equilibrium, spirit so that effect.Extract 20 parts in Rhizoma Gastrodiae, 30 parts of Radix Salviae Miltiorrhizaes, 3 parts on Flos Carthami, 10 parts of Flos Chrysanthemis, 10 parts of Radix Saposhnikoviaes, 50 parts of Radix Astragali, 6 parts of Rhizoma Chuanxiongs, 15 parts of Fructus Crataegis, 10 parts of the Cortexs Eucommiae, 30 parts of Radix Puerariaes, 10 parts of Scorpio, 30 parts of Concha Haliotidis, 10 parts of Rhizoma Alismatis, 20 parts of Semen Raphanis by weight, process by Hunan Province's processing concocted specification; Second step was that crude drug in whole and decoction pieces that processing cooks are dropped into multi-function extractor, the water that adds 6 times of drug weight, heat and decoct, the 60 minutes after-filtration that simmer in water after the boiling for the first time, the water that adds 4 times of drug weight for the second time 40 minutes after-filtration that simmer in water after boil; The 3rd step was dropped into vacuum concentrator with twice filtering liquid medicine, be concentrated to a certain degree and take out, drop into jacketed pan again and evaporate moisture content, when reaching about 1: 1.1 glue sap-shape, take out and put into the thermal cycle drying baker, dry the temperature inside the box is controlled between 50-65 ℃, after dry about 6 hours, take out absolutely dry glue sheet medicine, purify through conventional medicine purifying technique again, add excipient and form dissolved granule patent medicine.
Embodiment 2, and the film patent medicine that the formula proportion of embodiment 1 is made is used for clinical experiment, as the male patient Chen at 68 years old, excuse dusk, weak, hypomnesis, bradykinesia is more than 10 years, look into BP 160/90mmHg, refreshing clear, spirit is poor, face is purple dark, the build obesity, and the cervical vertebra neck is bent side pressure test (+), two pulmonary respiration sounds are clear, heart rate 80 times/minute, and rule is neat, abdominal tympanites, liver spleen do not lay one's hand on and, nervous system is not drawn pathologic reflex and is levied; Three of blood fat in the experimental data are: TG:1.748 TCH:6.821 HDL:1.45, and the cervical vertebra sheet is: six hyperosteogeny of cervical vertebra fourth, fifth,, electrocardiogram is shown: the ST section changes, and CT shows: cerebral arteriosclerosis.Be diagnosed as: hypertension, cerebral arteriosclerosis, cervical spondylosis, hyperlipemia.At this disease, every day, each 25 grams were after the treatment 45 to patient's this bright electuary secondary of taking after mixing it with water, dizzy, weak being clearly better, memory is recovered, and reaction is quick, and is refreshing clear, mental status takes a turn for the better, blood pressure maintains about 120/80mmHg, and the check electrocardiogram is roughly normal, and three checks of blood fat are: TG:1.217 TCH:4.181 HDL:1.13.Prove from present embodiment, the present invention to coronary dilating, blood fat reducing, protect diseases such as the heart, adjust blood pressure, improvement giddy, weak, hypomnesis, bradykinesia positive effect arranged.
Embodiment 3, and the film patent medicine that the formula proportion of embodiment 1 is made is used for clinical experiment, as the female patient Tan at 52 years old, excuse dusk, headache, right upper extremity is numb more than 2 years, and is refreshing clear, the asthenia face is looked into BP 160/100mmHg, and neck is bent side pressure test (+), the cervical vertebra tenderness, two pulmonary respiration sounds are clear, heart rate 55 times/minute, rule is neat, sound can, abdominal tympanites was found hypertension 5 years; ECG in the experimental data: sinus bradycardia, three of blood fat are: TG:3.607 TCH:5.972 HDL:1.03, cervical vertebra X sheet is: six hyperosteogeny of cervical vertebra fourth, fifth,, B ultrasonic shows: fatty liver.Be diagnosed as: hypertension, hyperlipemia, bradycardia, cervical spondylosis.At this disease, every day is to patient's electuary secondary of the present invention of taking after mixing it with water, each 25 grams, after the treatment 45, giddy, headache and right upper extremity numbness are clearly better, and refreshing clear, in high spirits, blood pressure maintains about 120/80mmHg, heart rate is 68 times/minute, and three checks of blood fat are: TG:1.952 TCH:5.102 HDL:1.31.Prove that from present embodiment the present invention has significant curative effect to diseases such as hypertension, hyperlipemia, bradycardia, cervical spondylosiss.
At dizzy, weak, hypomnesis, thinking respond go down, the patient of symptom such as fat, uncomfortable in chest, cardiopalmus, insomnia, hypertension, hyperlipemia, every day is to patient's electuary secondary of the present invention of taking after mixing it with water, each 25 grams, 30 days is a course of treatment, after taking three courses of treatment altogether, all pathological changes symptoms all can disappear or alleviate.By to the clinical observation of 1746 examples nearly, effective percentage reaches 98%.

Claims (3)

1, a kind of Xinmaikang medicine, it is characterized in that: with Rhizoma Gastrodiae, Flos Chrysanthemi, Concha Haliotidis, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, Radix Achyranthis Bidentatae, Rhizoma Alismatis is monarch drug, be used for suppressing the hyperactive liver and subsiding YANG, enriching yin and nourishing kidney, with Radix Salviae Miltiorrhizae, Flos Carthami, Radix Saposhnikoviae, Radix Astragali, Rhizoma Chuanxiong, Fructus Crataegi, the Cortex Eucommiae, Radix Puerariae, Scorpio, Semen Raphani is ministerial drug, being used to be turbid eliminates the phlegm, benefiting QI for activating blood circulation, invigorating the spleen and regulating the stomach, at first by the processing concocted specification crude drug in whole each component is carried out preliminary working respectively; Crude drug in whole that processing is cooked and decoction pieces drop into multi-function extractor then, the water that adds 4-8 times of drug weight, heat and decoct, 40 minutes to the 2 hours after-filtration that simmer in water after the boiling for the first time, the water that adds 2-6 times of drug weight for the second time boils after slow fire boils 30-60 minute after-filtration; Again twice filtering liquid medicine being dropped into vacuum concentrator concentrates, after concentrating, take out to drop in the jacketed pan and carry out water evaporates, put into the thermal cycle drying baker again, temperature in the drying baker is controlled between 50-65 ℃, take out after dry about 5-9 hour, absolutely dry glue sheet medicine, through purifying, add excipient and form dissolved granule again.
2, according to the described Xinmaikang medicine of claim 1, it is characterized in that: the ratio of crude drug in whole each component (weight ratio) is: Rhizoma Gastrodiae 15-25 part, Radix Salviae Miltiorrhizae 25-35 part, Flos Carthami 1-6 part, Flos Chrysanthemi 5-15 part, Radix Saposhnikoviae 5-15 part, Radix Astragali 40-60 part, Rhizoma Chuanxiong 1-10 part, Fructus Crataegi 10-25 part, Cortex Eucommiae 5-15 part, Radix Puerariae 25-35 part, Scorpio 5-15 part, Concha Haliotidis 25-35, Rhizoma Alismatis 5-15 part, Semen Raphani 15-25.
3, according to the described Xinmaikang medicine of claim 1, it is characterized in that: the optimum formula ratio (weight ratio) of crude drug in whole each component is: 20 parts in Rhizoma Gastrodiae, 30 parts of Radix Salviae Miltiorrhizaes, 3 parts on Flos Carthami, 10 parts of Flos Chrysanthemis, 10 parts of Radix Saposhnikoviaes, 50 parts of Radix Astragali, 6 parts of Rhizoma Chuanxiongs, 15 parts of Fructus Crataegis, 10 parts of the Cortexs Eucommiae, 30 parts of Radix Puerariaes, 10 parts of Scorpio, 30 parts of Concha Haliotidis, 10 parts of Rhizoma Alismatis, 20 parts of Semen Raphanis.
CNB001135155A 2000-06-30 2000-06-30 Xinmaikang medicine Expired - Lifetime CN1135107C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001135155A CN1135107C (en) 2000-06-30 2000-06-30 Xinmaikang medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001135155A CN1135107C (en) 2000-06-30 2000-06-30 Xinmaikang medicine

Publications (2)

Publication Number Publication Date
CN1307876A true CN1307876A (en) 2001-08-15
CN1135107C CN1135107C (en) 2004-01-21

Family

ID=4583291

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001135155A Expired - Lifetime CN1135107C (en) 2000-06-30 2000-06-30 Xinmaikang medicine

Country Status (1)

Country Link
CN (1) CN1135107C (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979020A (en) * 2010-12-02 2011-02-23 广西正堂药业有限责任公司 Chinese medicinal preparation for treating high blood pressure
CN102526377A (en) * 2012-02-16 2012-07-04 陕西天铭岭南春茶业有限公司 Chinese medicinal herb tea for contributing to cardiovascular and cerebrovascular diseases and promoting sleeping and preparation method thereof
CN102670958A (en) * 2012-04-28 2012-09-19 朱凤华 Chinese medicine powder for treating cerebral thrombosis and hypertension
CN103751622A (en) * 2014-02-13 2014-04-30 姜吉双 Pharmaceutical composition for treating coronary heart disease
CN104324223A (en) * 2014-11-27 2015-02-04 岑明 Traditional Chinese medicine preparation for treating hypertension
CN104623330A (en) * 2015-01-14 2015-05-20 姜丽莎 Chinese medicinal composition for treating hyperlipidemia
CN104873896A (en) * 2015-05-26 2015-09-02 李厚建 Traditional Chinese medicine composition for treating stroke caused by hypertension
CN105194332A (en) * 2015-11-02 2015-12-30 朱惠连 Traditional Chinese medicine for treating non-alcoholic fatty liver disease
CN105288068A (en) * 2015-11-10 2016-02-03 王冬梅 Preparation for treatment of arteriosclerosis and preparing method thereof
CN108887686A (en) * 2018-07-05 2018-11-27 杭州娃哈哈科技有限公司 A kind of preparation method with the extract for improving hypertension function
CN109430487A (en) * 2019-01-11 2019-03-08 郑甫富 A kind of antihypertensive healthcare tea beverage and preparation method thereof

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979020A (en) * 2010-12-02 2011-02-23 广西正堂药业有限责任公司 Chinese medicinal preparation for treating high blood pressure
CN102526377A (en) * 2012-02-16 2012-07-04 陕西天铭岭南春茶业有限公司 Chinese medicinal herb tea for contributing to cardiovascular and cerebrovascular diseases and promoting sleeping and preparation method thereof
CN102670958A (en) * 2012-04-28 2012-09-19 朱凤华 Chinese medicine powder for treating cerebral thrombosis and hypertension
CN103751622B (en) * 2014-02-13 2016-02-03 姜吉双 A kind of pharmaceutical composition for the treatment of coronary heart disease
CN103751622A (en) * 2014-02-13 2014-04-30 姜吉双 Pharmaceutical composition for treating coronary heart disease
CN104324223A (en) * 2014-11-27 2015-02-04 岑明 Traditional Chinese medicine preparation for treating hypertension
CN104324223B (en) * 2014-11-27 2017-10-03 岑明 A kind of Chinese medicine preparation for treating hypertension
CN104623330A (en) * 2015-01-14 2015-05-20 姜丽莎 Chinese medicinal composition for treating hyperlipidemia
CN104873896A (en) * 2015-05-26 2015-09-02 李厚建 Traditional Chinese medicine composition for treating stroke caused by hypertension
CN105194332A (en) * 2015-11-02 2015-12-30 朱惠连 Traditional Chinese medicine for treating non-alcoholic fatty liver disease
CN105288068A (en) * 2015-11-10 2016-02-03 王冬梅 Preparation for treatment of arteriosclerosis and preparing method thereof
CN108887686A (en) * 2018-07-05 2018-11-27 杭州娃哈哈科技有限公司 A kind of preparation method with the extract for improving hypertension function
CN109430487A (en) * 2019-01-11 2019-03-08 郑甫富 A kind of antihypertensive healthcare tea beverage and preparation method thereof

Also Published As

Publication number Publication date
CN1135107C (en) 2004-01-21

Similar Documents

Publication Publication Date Title
CN1189366A (en) Gastritis pills
CN1135107C (en) Xinmaikang medicine
CN103977358A (en) Oral traditional Chinese medicine for lowering lipid and protecting liver
CN101934041A (en) Chinese medicinal herb for treating pleurisy
CN101199738B (en) Medicament for treating cough and gasp disease
CN101411804B (en) Mixture for clearing lung-heat and preparation method thereof
CN101376016B (en) Method for preparing Chinese medicine for treating hyperlipemia
CN103623385B (en) A kind of Chinese medicine for the treatment of oral ulcer
CN102641486A (en) Preparation method of traditional Chinese medicine for treating blood-deficiency-type colonitis
CN1097621A (en) Anti-cancer powder
CN102274482A (en) Chinese medicinal preparation for treating diabetes
CN102631591B (en) Method for preparing traditional Chinese medicine (TCM) for treating edema type colitis
CN1352957A (en) Medicine for treating cervical vertebra disease
CN103784829A (en) Chinese herbal medicine for treating pleurisy
CN102641488A (en) Preparation method of traditional Chinese medicine for treating spontaneous-perspiration-type colonitis
CN113633722A (en) A Chinese medicinal composition for treating coronary heart disease and arrhythmia, and its preparation method
CN105963450A (en) Traditional Chinese medicine composition for treating dizziness and faintness
CN102166311B (en) Preparation method of Chinese medicine for treating spleen-deficiency sthenic liver-energy hyperthyroidism
CN109370855A (en) It is a kind of with improving taste, mitigate abdomen secret anguish and improve health liquor and preparation method thereof of sleep function
CN104740227A (en) Traditional Chinese medicine preparation for treating infantile diarrhea
CN1098642A (en) Dysmenorrhoea powder and production technology thereof
CN1135106C (en) Naomaisu medicine
CN1169557C (en) Chinese medicine for treating gout and process for preparing its instant particles
CN104491460B (en) A kind of Traditional Chinese medicine liniment for the treatment of oral ulcer
CN103550745B (en) Traditional Chinese medicine composition for treating hypotension and preparation method of traditional Chinese medicine composition for treating hypotension

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20040121